{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T08:58:16Z","timestamp":1792486696063,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015317","name":"Mustansiriyah University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015317","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.clim.2026.110750","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T15:31:45Z","timestamp":1784388705000},"page":"110750","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Serum soluble CD25, Galectin-9, and CXCL9 as immunological markers differentiating complete remission from refractory acute myeloid leukemia"],"prefix":"10.1016","volume":"287","author":[{"given":"Abdullah Salim","family":"Al-Karawi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Saad","family":"Al-Budairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali M.","family":"Atoom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clim.2026.110750_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/jcm5030033","article-title":"Acute myeloid leukemia: a concise review","volume":"5","author":"Saultz","year":"2016","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.clim.2026.110750_bb0010","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2016.50","article-title":"Acute myeloid leukemia: a comprehensive review and 2016 update","volume":"6","author":"De Kouchkovsky","year":"2016","journal-title":"Blood Cancer J."},{"issue":"1","key":"10.1016\/j.clim.2026.110750_bb0015","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s43042-024-00563-w","article-title":"Prognosis and treatment in acute myeloid leukemia: a comprehensive review","volume":"25","author":"Debnath","year":"2024","journal-title":"Egyptian Journal of Medical Human Genetics"},{"key":"10.1016\/j.clim.2026.110750_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2024.05.020","article-title":"Elevated circulating soluble interleukin-2 receptor (sCD25) level is associated with prefrontal excitatory-inhibitory imbalance in individuals with chronic pain: a proton MRS study","volume":"120","author":"Ma","year":"2024","journal-title":"Brain Behav. Immun."},{"issue":"null","key":"10.1016\/j.clim.2026.110750_bb0025","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2147\/ITT.S500229","article-title":"Cytokine couture: designer IL2 molecules for the treatment of disease","volume":"14","author":"Dashwood","year":"2025","journal-title":"Immunotargets Ther."},{"issue":"1","key":"10.1016\/j.clim.2026.110750_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/lymphatics3010001","article-title":"Soluble IL-2R as a marker of T cell activation in immune-mediated diseases: review and case-based interpretation","volume":"3","author":"Oportus","year":"2025","journal-title":"Lymphatics"},{"issue":"10","key":"10.1016\/j.clim.2026.110750_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047748","article-title":"Soluble IL-2R\u03b1 (sCD25) exacerbates autoimmunity and enhances the development of Th17 responses in mice","volume":"7","author":"Russell","year":"2012","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.clim.2026.110750_bb0040","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s40200-024-01461-z","article-title":"A closer look at Galectin-3: its association with gestational diabetes mellitus revealed by systematic review and meta-analysis","volume":"23","author":"Bahreiny","year":"2024","journal-title":"J. Diabetes Metab. Disord."},{"key":"10.1016\/j.clim.2026.110750_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1332205","article-title":"Galectin-9 in cancer therapy: from immune checkpoint ligand to promising therapeutic target","volume":"11","author":"Zhang","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.clim.2026.110750_bb0050","article-title":"Galectin family members: emerging novel targets for lymphoma therapy?","volume":"12","author":"Shi","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.clim.2026.110750_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102575","article-title":"Galectin-9 bridges human B cells to vascular endothelium while programming regulatory pathways","volume":"117","author":"Chakraborty","year":"2021","journal-title":"J. Autoimmun."},{"issue":"2","key":"10.1016\/j.clim.2026.110750_bb0060","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.147","article-title":"Role of chemokine systems in cancer and inflammatory diseases","volume":"3","author":"Li","year":"2022","journal-title":"MedComm"},{"issue":"18","key":"10.1016\/j.clim.2026.110750_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15184555","article-title":"The role of CXCR1, CXCR2, CXCR3, CXCR5, and CXCR6 ligands in molecular cancer processes and clinical aspects of acute myeloid leukemia (AML)","volume":"15","author":"Korbecki","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.clim.2026.110750_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.584766","article-title":"Risk stratification in acute myeloid leukemia using CXCR gene signatures: a bioinformatics analysis","volume":"10","author":"Lu","year":"2020","journal-title":"Front. Oncol."},{"issue":"8s","key":"10.1016\/j.clim.2026.110750_bb0075","first-page":"452","article-title":"The relationship between renal impairment and specific laboratory markers: a comprehensive investigation focusing on athletes","volume":"6","author":"Asaad","year":"2023","journal-title":"J. ReAttach Ther. Dev. Divers."},{"issue":"16","key":"10.1016\/j.clim.2026.110750_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26167998","article-title":"Galectin-9-an emerging Glyco-immune checkpoint target for Cancer therapy","volume":"26","author":"Karkempetzaki","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.clim.2026.110750_bb0085","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1007\/s00277-025-06387-x","article-title":"Galectin-9: a double-edged sword in acute myeloid leukemia","volume":"104","author":"Aval","year":"2025","journal-title":"Ann. Hematol."},{"issue":"5","key":"10.1016\/j.clim.2026.110750_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70345","article-title":"Unravelling T cell exhaustion through co-inhibitory receptors and its transformative role in cancer immunotherapy","volume":"15","author":"Xiang","year":"2025","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.clim.2026.110750_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00310","article-title":"Inhibitory receptors beyond T cell exhaustion","volume":"6","author":"Fuertes Marraco","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2026.110750_bb0100","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jcpa.2019.10.003","article-title":"Galectin-3 expression correlates with post-surgical survival in canine oral melanomas","volume":"173","author":"Vargas","year":"2019","journal-title":"J. Comp. Pathol."},{"issue":"7","key":"10.1016\/j.clim.2026.110750_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.7113","article-title":"Effect of galectin-1 on prognosis and responsiveness of immune checkpoint plus tyrosine kinase inhibition in renal cell carcinoma","volume":"13","author":"Wang","year":"2024","journal-title":"Cancer Med."},{"issue":"6","key":"10.1016\/j.clim.2026.110750_bb0110","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1182\/bloodadvances.2024013304","article-title":"Validation of the revised 2022 European LeukemiaNet risk stratification in adult patients with acute myeloid leukemia","volume":"9","author":"Ruhnke","year":"2025","journal-title":"Blood Adv."},{"issue":"12","key":"10.1016\/j.clim.2026.110750_bb0115","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.clim.2026.110750_bb0120","doi-asserted-by":"crossref","first-page":"6711","DOI":"10.1002\/cam4.5461","article-title":"Sex differences in adults with acute myeloid leukemia and the impact of sex on overall survival","volume":"12","author":"Stabellini","year":"2023","journal-title":"Cancer Med."},{"issue":"4","key":"10.1016\/j.clim.2026.110750_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/curroncol32040204","article-title":"Sex and gender in myeloid and lymphoblastic leukemias and multiple myeloma: from molecular mechanisms to clinical outcomes","volume":"32","author":"Ansarian","year":"2025","journal-title":"Curr. Oncol."},{"issue":"1","key":"10.1016\/j.clim.2026.110750_bb0130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s42358-025-00517-9","article-title":"Impact of male sex in clinical and laboratory features of systemic sclerosis","volume":"66","author":"Luppino-Assad","year":"2026","journal-title":"Adv. Rheumatol."},{"issue":"3","key":"10.1016\/j.clim.2026.110750_bb0135","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1177\/17456916231202685","article-title":"A systematic review and new analyses of the gender-equality paradox","volume":"20","author":"Herlitz","year":"2025","journal-title":"Perspect. Psychol. Sci."},{"key":"10.1016\/j.clim.2026.110750_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1626082","article-title":"Autoimmune disease: genetic susceptibility, environmental triggers, and immune dysregulation. Where can we develop therapies?","volume":"16","author":"Kumar","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2026.110750_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2026.110072","article-title":"Environmental epigenetics: new horizons in redefining biological and health outcomes","volume":"208","author":"Faraji","year":"2026","journal-title":"Environ. Int."},{"issue":"8","key":"10.1016\/j.clim.2026.110750_bb0150","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41408-021-00533-0","article-title":"The long shadow of socioeconomic deprivation over the modern management of acute myeloid leukemia: time to unravel the challenges","volume":"11","author":"John","year":"2021","journal-title":"Blood Cancer J."},{"issue":"26","key":"10.1016\/j.clim.2026.110750_bb0155","doi-asserted-by":"crossref","first-page":"14445","DOI":"10.1039\/C7RA13298K","article-title":"Metabolomics analysis of salvage chemotherapy on refractory acute myeloid leukemia patients","volume":"8","author":"Zheng","year":"2018","journal-title":"RSC Adv."},{"issue":"3","key":"10.1016\/j.clim.2026.110750_bb0160","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3109\/08830181003792803","article-title":"Neonatal sepsis and neutrophil insufficiencies","volume":"29","author":"Melvan","year":"2010","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.clim.2026.110750_bb0165","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3389\/fphys.2018.00113","article-title":"Neutrophil: a cell with many roles in inflammation or several cell types?","volume":"9","author":"Rosales","year":"2018","journal-title":"Front. Physiol."},{"issue":"4","key":"10.1016\/j.clim.2026.110750_bb0170","doi-asserted-by":"crossref","DOI":"10.33091\/amj.2025.159680.2222","article-title":"Biomarkers of sepsis severity: a comparative evaluation of immunological and biochemical parameters","volume":"21","author":"Alshammary","year":"2025","journal-title":"Al-Anbar Med. J."},{"issue":"2","key":"10.1016\/j.clim.2026.110750_bb0175","first-page":"205","article-title":"Genome editing in medicine: tools and challenges","volume":"28","author":"Petraityt\u0117","year":"2021","journal-title":"Acta Med Litu"},{"issue":"6","key":"10.1016\/j.clim.2026.110750_bb0180","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1016\/j.ymthe.2025.03.026","article-title":"Recent advances in therapeutic gene-editing technologies","volume":"33","author":"Liu","year":"2025","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.clim.2026.110750_bb0185","first-page":"15","article-title":"NPM1 and FLT3-ITD\/TKD gene mutations in acute myeloid leukemia","volume":"15","author":"Naseem","year":"2021","journal-title":"Int. J. Hematol. Oncol. Stem Cell Res."},{"issue":"7","key":"10.1016\/j.clim.2026.110750_bb0190","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.3390\/biomedicines11071805","article-title":"Genetic, phenotypic, and clinical heterogeneity of NPM1-mutant acute myeloid Leukemias","volume":"11","author":"Testa","year":"2023","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.clim.2026.110750_bb0195","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s10238-025-01557-7","article-title":"The value of plasma sCD25 in diagnosis, therapeutic efficacy, and prognosis of acute myeloid leukemia","volume":"25","author":"Wang","year":"2025","journal-title":"Clin. Exp. Med."},{"issue":"7","key":"10.1016\/j.clim.2026.110750_bb0200","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1177\/0961203318760993","article-title":"Serum soluble CD25 as a risk factor of renal impairment in systemic lupus erythematosus - a prospective cohort study","volume":"27","author":"Zhang","year":"2018","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.clim.2026.110750_bb0205","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1182\/bloodadvances.2022007953","article-title":"sCD25 as an independent adverse prognostic factor in adult patients with HLH: results of a multicenter retrospective study","volume":"7","author":"Wimmer","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.clim.2026.110750_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.669817","article-title":"Prognostic value of Galectin-9 relates to programmed death-ligand 1 in patients with multiple myeloma","volume":"11","author":"Lee","year":"2021","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.clim.2026.110750_bb0215","doi-asserted-by":"crossref","first-page":"571","DOI":"10.21037\/tcr.2018.05.18","article-title":"Galectin-9 as a prognostic biomarker in small cell lung cancer","volume":"7","author":"Xu","year":"2018","journal-title":"Transl. Cancer Res."},{"issue":"7","key":"10.1016\/j.clim.2026.110750_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076174","article-title":"Galectin-9 in gastroenterological cancer","volume":"24","author":"Morishita","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.clim.2026.110750_bb0225","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s13048-023-01248-5","article-title":"CT radiomics prediction of CXCL9 expression and survival in ovarian cancer","volume":"16","author":"Gu","year":"2023","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.clim.2026.110750_bb0230","article-title":"Galectins-1, \u22123 and \u22129 in leukemia: mechanistic insights and therapeutic translation","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2026.110750_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2024.104890","article-title":"Immunomodulation by galectin-9: distinct role in T cell populations, current therapeutic avenues and future potential","volume":"407","author":"Gossink","year":"2025","journal-title":"Cell. Immunol."},{"issue":"6","key":"10.1016\/j.clim.2026.110750_bb0240","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1369\/jhc.2010.955237","article-title":"A novel clinically relevant animal model for studying galectin-3 and its ligands during colon carcinogenesis","volume":"58","author":"Hill","year":"2010","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.clim.2026.110750_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2024.116207","article-title":"\u0392-Galactosidase-activated near-infrared AIEgen for ovarian cancer imaging in vivo","volume":"255","author":"Xu","year":"2024","journal-title":"Biosens. Bioelectron."},{"issue":"10","key":"10.1016\/j.clim.2026.110750_bb0250","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/s41416-022-01763-0","article-title":"CXCL9 inhibits tumour growth and drives anti-PD-L1 therapy in ovarian cancer","volume":"126","author":"Seitz","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.clim.2026.110750_bb0255","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","article-title":"CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation - a target for novel cancer therapy","volume":"63","author":"Tokunaga","year":"2018","journal-title":"Cancer Treat. Rev."},{"issue":"18","key":"10.1016\/j.clim.2026.110750_bb0260","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26189087","article-title":"Differential expression of galectin-1 and galectin-9 in immune-mediated inflammatory diseases","volume":"26","author":"Valero-Mart\u00ednez","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.clim.2026.110750_bb0265","doi-asserted-by":"crossref","DOI":"10.1177\/00368504211039590","article-title":"Soluble interleukin-2 receptor as a predictive and prognostic marker for patients with familial breast cancer","volume":"104","author":"Gonda","year":"2021","journal-title":"Sci. Prog."},{"issue":"2","key":"10.1016\/j.clim.2026.110750_bb0270","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001849","article-title":"Galectin-9 expression defines exhausted T cells and impaired cytotoxic NK cells in patients with virus-associated solid tumors","volume":"8","author":"Okoye","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.clim.2026.110750_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121585","article-title":"Therapeutic potential of targeting galectins \u2013 a biomaterials-focused perspective","volume":"286","author":"Martin-Salda\u00f1a","year":"2022","journal-title":"Biomaterials"},{"issue":"11","key":"10.1016\/j.clim.2026.110750_bb0280","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1002\/cam4.934","article-title":"CXCL9: evidence and contradictions for its role in tumor progression","volume":"5","author":"Ding","year":"2016","journal-title":"Cancer Med."},{"key":"10.1016\/j.clim.2026.110750_bb0285","first-page":"5403","article-title":"The chemokines CXCL9, CXCL10, and CXCL11 differentially stimulate g\u03b1 i -independent signaling and actin responses in human intestinal myofibroblasts","volume":"175","author":"Kouroumalis","year":"2005","journal-title":"Journal of immunology (Baltimore, Md.\u202f: 1950)"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661626000884?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661626000884?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T23:19:10Z","timestamp":1788045550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661626000884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":57,"alternative-id":["S1521661626000884"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2026.110750","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum soluble CD25, Galectin-9, and CXCL9 as immunological markers differentiating complete remission from refractory acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2026.110750","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110750"}}